drugset / Trial / NCT00460733

SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.

NCT00460733

Phase 4 Completed 141 enrolled Sanofi Procter and Gamble · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of risedronate sodium (Actonel®) after a wrist fracture in postmenopausal women.

Timeline

Start
2007-03
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Risedronate Small molecule 35 mg
Comparator Calcium carbonate Other / unclassified 1000 mg
Comparator Vitamine D3 Unknown 400 iu

Indications

No indication recorded.